Medexprim has been selected to join the Digital Health Scale-Up 2025 program to accelerate its internationalization in Europe.
On April 6, the Digital Health Scale-Up 2025 program was launched, an initiative organized under the French presidency of the Council of the European Union, carried out by the French Healthcare Association, BpiFrance, EIT Health and AI for Health, with support from the Ministry of Europe and Foreign Affairs.
The Digital Health Scale Up 2025 program aims to accelerate the internationalization of French digital health start-ups in Europe, within a collaborative framework of knowledge-sharing between the 6 selected start-ups, experts and institutions in the ecosystem. Jean-Marc Bourez, Managing Director, EIT Health: “Companies that manage to invest in other countries thanks to their value proposition have a 50% greater chance of success than others. Therefore, we have joined forces and created Digital Health Scale Up.”
Medexprim will be coached by mentors, including Daphne Richet-Cooper, Director of Bilateral Relations at Sanofi, who will offer their expertise to the laureates in order to be “the climbing companions of their international expansion” (French Healthcare Association).
Romain Cazavan, CEO of Medexprim: “We are happy to participate in this outstanding collective intelligence initiative that highlights the French ecosystem of innovation in health. Europe is a pillar of Medexprim’s identity. This partnership will allow us to grow Medexprim in Europe and to expand our network of European partners to build high-quality European datasets by disease. We are proud to be among the first laureates of this program which is in line with a strong government policy, and to contribute to establishing France as the European reference in digital health.”
REAL-WORLD EVIDENCE FOR BETTER CARE
Medexprim is Europe’s leading provider of secure imaging and clinical data extraction to accelerate medical research. As a real-world data specialist, we build bridges between leading academic hospitals and pharmaceutical, AI and medical device companies. In compliance with the GDPR, we help hospitals drive their own clinical research strategy and extract value from their data, through our software and services designed with and for clinicians. We provide our partners with secure access to regulatory-grade data. Medexprim aims to build multicentric disease-specific data lakes to serve oncology, neurology and cardiology. We help solve the “one patient, one disease, one treatment” equation to develop precision medicine for better care.
Medexprim Press contact: Anne-Sophie Labeta